| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.7 |